Company Filing History:
1 out of 93 
1 out of 3 Years Active: 2012
Title: Benoît Adam: Innovator in Leukotriene Research
Introduction
Benoît Adam is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of biochemistry, particularly in the study of leukotrienes. His work has implications for both human and animal health, showcasing the importance of his research in medical science.
Latest Patents
Benoît Adam holds a patent for a "Leukotriene B4 binding soluble lipocalin receptor from Ixodes ricinus." This patent involves the Leukotriene B4 binding polypeptide obtained from Ixodes ricinus. The polypeptide, along with its encoding polynucleotide and related polypeptides, can be utilized as research reagents and for treatments and diagnostics specific to various diseases in both animals and humans. He has 1 patent to his name.
Career Highlights
Throughout his career, Benoît Adam has worked with prestigious institutions such as Université Libre De Bruxelles and Faculté Universitaire Des Sciences Agronomiques De Gembloux. His research has been pivotal in advancing our understanding of leukotrienes and their role in disease mechanisms.
Collaborations
Benoît has collaborated with esteemed colleagues, including Edmond Godfroid and Jérôme Beaufays. These partnerships have enriched his research and contributed to the broader scientific community.
Conclusion
Benoît Adam's innovative work in leukotriene research highlights his role as a significant contributor to medical science. His patent and collaborations reflect his commitment to advancing knowledge in this vital area.